Value of FDG PET/CT in patient management and outcome of skeletal and soft tissue sarcomas

Sara Sheikhbahaei, Charles Marcus, Nima Hafezi-Nejad, Mehdi Taghipour, Rathan M. Subramaniam

Research output: Contribution to journalReview articlepeer-review

22 Scopus citations

Abstract

Fluorodeoxyglucose (FDG)-PET/computed tomography (CT) has been increasingly used in bone and soft tissue sarcomas and provides advantages in the initial tumor staging, tumor grading, therapy assessment, and recurrence detection. FDG-PET/CT metabolic parameters are reliable predictors of survival in sarcomas and could be implemented in risk stratification models along with other prognostic factors in these patients.

Original languageEnglish (US)
Pages (from-to)375-393
Number of pages19
JournalPET Clinics
Volume10
Issue number3
DOIs
StatePublished - Jul 1 2015

Keywords

  • Computed tomography
  • Fluorodeoxyglucose
  • PET
  • Patient management
  • Skeletal sarcoma
  • Soft tissue sarcoma

ASJC Scopus subject areas

  • Radiation
  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Value of FDG PET/CT in patient management and outcome of skeletal and soft tissue sarcomas'. Together they form a unique fingerprint.

Cite this